Pākuʻi Belimumab

Anter

• Ma mua o ka hoʻohana ʻana i belimumab,
• Hoʻokumu paha ʻo Belimumab i nā hopena ʻaoʻao. E haʻi i kāu kauka inā koʻikoʻi kekahi o kēia mau ʻōuli a mai hele aku paha:
• Hiki i kekahi o nā hopena ʻaoʻao ke koʻikoʻi. Inā ʻoe e ʻike i kekahi o kēia mau ʻōuli a i ʻole nā ​​mea i helu ʻia i ka ʻaoʻao HOW, e kāhea koke i kāu kauka:

Hoʻohana ʻia ʻo Belimumab me nā lāʻau ʻē aʻe e mālama ai i kekahi ʻano o ka systemus lupus erythematosus (SLE a i ʻole lupus; kahi maʻi autoimmune kahi e hoʻouka ai ka ʻōnaehana pale i nā ʻāpana olakino o ke kino e like me nā hono, ka ʻili, nā kīʻaha koko, a me nā ʻokena) i nā mākua a me nā keiki 5 makahiki a ʻoi. Hoʻohana pū ʻia ʻo Belimumab me nā lāʻau ʻē aʻe e mālama i ka nephritis lupus (kahi maʻi autoimmune kahi e hoʻouka ai ka ʻōnaehana pale maʻi i nā puʻupaʻa) i nā mākua. Aia ʻo Belimumab i kahi papa o nā lāʻau i kapa ʻia he monoclonal antibodies. Hana ia ma ka pale ʻana i ka hana o kekahi protein i ka poʻe me SLE a me lupus nephritis.

Hele mai ʻo Belimumab ma ke ʻano he pauka e kāwili ʻia i loko o kahi hopena e hoʻokomo ʻia i loko o ke aniani (i kahi aa) i nā mākua a me nā keiki 5 mau makahiki a ʻoi paha. Hele mai ʻo Belimumab ma ke ʻano he hopena (wai) i loko o kahi autoinjector a i ʻole syringe prefilled e pahu i subcutaneously (ma lalo o ka ʻili) i nā mākua. Ke hāʻawi intravenously, hāʻawi pinepine ʻia ia ma ka liʻiliʻi i hoʻokahi hola e ke kauka a kahu hānai paha i kēlā me kēia 2 mau pule no ʻekolu mau kaukana, a laila hoʻokahi manawa i kēlā me kēia 4 mau pule. E hoʻoholo kāu kauka i ka manawa e loaʻa ai iā ʻoe ka belimumab intravenous ma muli o ka pane o kou kino i kēia lāʻau. Ke hāʻawi ʻia subcutaneously, hāʻawi pinepine ʻia ia i hoʻokahi manawa ma ka pule i ka lā like i kēlā me kēia pule.

E loaʻa iā ʻoe kāu mahele lāʻau subcutaneous mua o ka belimumab injection i ke keʻena o kāu kauka. Inā ʻoe e ʻoki ana i belimumab injection subcutaneously e ʻoe iho ma ka home a i ʻole he hoaaloha a ʻohana paha e hoʻokomo i ka lāʻau iā ʻoe, e hōʻike aku kāu kauka iā ʻoe a i ʻole i ke kanaka nāna e hoʻokomo i ka lāʻau pehea e hoʻopili ai iā ia. ʻO ʻoe a me ke kanaka nāna e hoʻokomo i ka lāʻau e pono e heluhelu i nā ʻōkuhi i kākau ʻia no ka hoʻohana ʻana me ka lāʻau.

Wehe i ka autoinjector a i ʻole ka syringe prefilled mai ka pahu hau a ʻae iā ia e hōʻea i ka lumi i 30 mau minuke ma mua o kou mākaukau e hoʻokomo i ka inikua belimumab. Mai hoʻāʻo e hoʻomehana i ka lāʻau i ka hoʻomehana ʻana iā ia i loko o ka hawewe uila, e waiho ana iā ia i ka wai mehana, a i ʻole ma o nā ʻano hana ʻē aʻe. E akāka ka hopena i ka opalescent a kala ʻole i ka melemele ākea. Kāhea i kāu kauka lāʻau inā he mau pilikia me ka pūʻolo a i ʻole ke ʻūlū a mai hoʻokomo i ka lāʻau.

Hiki iā ʻoe ke hoʻopili i ka injection belimumab ma ke alo o nā ʻūhā a ma nā wahi āpau paha o kou ʻōpū koe wale kou piko (pihi ʻōpū) a me kahi ʻona 2 mau ʻīniha a puni ia. Mai hoʻokomo i ka lāʻau i loko o ka ʻili i palupalu, ʻōpala, ʻulaʻula, paʻakikī, ʻaʻole paʻa ʻole. Koho i kahi wahi ʻokoʻa i kēlā me kēia manawa āu e hoʻopili ai i ka lāʻau.

Hoʻokumu paha ʻo Belimumab i nā hopena koʻikoʻi i ka wā a ma hope o kou loaʻa ʻana i ka lāʻau. E nānā pono kahi kauka a kahu hānai paha iā ʻoe ke loaʻa nei ka infusion a ma hope o ka hoʻopili ʻana e ʻike pono ʻaʻole ʻoe i kahi hopena koʻikoʻi i ka lāʻau. Hāʻawi ʻia ʻoe i nā lāʻau ʻē aʻe e mālama a kōkua i ka pale ʻana i nā hopena i belimumab. E haʻi koke i kāu kauka a kahu hānai paha inā ʻike ʻoe i kekahi o nā ʻōuli e hiki ke hana ʻia i ka wā o ka infusion intravenous a i ʻole ka injection subcutaneus a i ʻole hoʻokahi pule ma hope o kou loaʻa ʻana i ka lāʻau. ʻumeʻume; hives; pehu o ka maka, maka, waha, ʻāʻī, elelo, a i ʻole mau lehelehe; pilikia i ka hanu ʻana a i ʻole ke ale ʻana; hū a i ʻole ka pōkole o ka hanu; hopohopo; pāheʻe; ʻūpā; maule ana; ʻeha poʻo; nausea; kuni; haʻalulu; ka hopu ʻana; ʻeha ka ʻili; a me ke kuʻi puʻuwai.

Kōkua ʻo Belimumab i ka mālama ʻana i ka lupus akā ʻaʻole ia e hoʻōla iā ia. E nānā pono kāu kauka iā ʻoe e ʻike i ka maikaʻi o ka hana a belimumab iā ʻoe. Lōʻihi paha ka manawa ma mua o kou ʻike i ka pono piha o ka belimumab. He mea nui e haʻi i kāu kauka i kou ʻano i kou wā e mālama ai.

E hāʻawi aku kāu kauka a mea kauka paha iā ʻoe i ka palapala ʻike hoʻomanawanui o ka mea hana (Ke alakaʻi lāʻau) ke hoʻomaka ʻoe i ka lāʻau me belimumab a i kēlā me kēia manawa e hoʻopiha hou i kāu kauka. E heluhelu pono i ka ʻike a nīnau i kāu kauka a kauka paha inā he nīnau kāu. Hiki iā ʻoe ke kipa aku i ka pūnaewele ʻo Food and Drug Administration (FDA) http://www.fda.gov/Drugs/DrugSafety/ucm085729.htm a i ʻole ka pūnaewele o ka mea hana e kiʻi i ka Medication Guide.

Kau ʻia kēia lāʻau no nā hoʻohana ʻē aʻe; e noi i kāu kauka a kauka paha no ka ʻike hou aku.

Ma mua o ka hoʻohana ʻana i belimumab,

• e haʻi i kāu kauka a me ka mea kauka lāʻau inā he maʻi ʻoe i ka belimumab, nā lāʻau ʻē aʻe, a i ʻole kekahi o nā mea hana i ka belimumab injection. E noi i kāu kauka lāʻau a nānā i ke alakaʻi lāʻau no kahi papa inoa o nā mea hoʻohui.
• e haʻi i kāu kauka a me ka mea kauka lāʻau i nā lāʻau lapaʻau, nā wikamina, nā mea hoʻopihapiha, a me nā huahana lāʻau āu e lawe nei a hoʻolālā paha e lawe. E kuhikuhi pono i kekahi o kēia mau mea: cyclophosphamide intravenous; a me nā antibodies monoclonal a i ʻole nā ​​lāʻau biologic ʻē aʻe. Pono paha kāu kauka e hoʻololi i nā kaha o kāu mau lāʻau a nānā pono iā ʻoe no nā hopena ʻaoʻao.
• e haʻi i kāu kauka inā loaʻa ʻoe i kahi maʻi a inā loaʻa paha ʻoe i kahi maʻi e hoʻi mai ana, kaumaha a manaʻo paha e hōʻeha a pepehi paha iā ʻoe iho, a i ʻole ka maʻi ʻaʻai.
• e haʻi i kāu kauka inā hāpai ʻoe a i ʻole hoʻolālā e hāpai. ʻAʻole ʻike ʻia inā lawe belimumab i ka wā hāpai hiki ke hōʻeha i kāu pēpē i hānau ʻole ʻia. Inā koho ʻoe e pale i ka hāpai ʻana, pono ʻoe e hoʻohana i ka kaohi hānau kūpono i kāu mālama ʻana me belimumab a no 4 mau mahina ma hope o kāu hopena hope loa. E kamaʻilio me kāu kauka e pili ana i nā ʻano hana hānau hiki iā ʻoe ke hoʻohana i kāu wā o kāu mālama ʻana. Inā hāpai ʻoe i kou wā lapaʻau me belimumab, e kāhea i kāu kauka.
• e haʻi i kāu kauka inā e hānai ana ʻoe i ka waiū.
• inā ke ʻoki nei ʻoe, e like me ke kaha ʻana o nā niho, e haʻi i ke kauka a i ʻole kauka niho paha e hoʻohana nei ʻoe i belimumab.
• ʻaʻohe o nā lāʻau āpau ke kamaʻilio ʻole ʻia me kāu kauka. E haʻi i kāu kauka inā ua loaʻa iā ʻoe kahi lāʻau lapaʻau i loko o 30 mau lā i hala.

Inā ʻaʻole haʻi kāu kauka iā ʻoe, e hoʻomau i kāu papaʻai maʻamau.

Inā haʻalele ʻoe i kahi manawa e loaʻa ai kahi infus belimumab, e kāhea koke i kāu kauka.

Inā ʻike ʻoe i kāu lāʻau subcutaneous o ka belimumab injection, e hoʻokomo i ka lāʻau i hala i kou hoʻomanaʻo ʻana iā ia. A laila, e hoʻomoʻi i kāu mahele lāʻau aʻe i kāu manawa i hoʻonohonoho mau ʻia a hoʻomau i ka hana ʻana i kēlā me kēia pule e pili ana i ka lā hou i injected. Mai hoʻokomo i kahi lāʻau pālua e pani no kahi mea i hala. Kāhea i kāu kauka a kauka paha inā makemake ʻoe i kōkua e hoʻoholo i ka manawa e hoʻopili ai i ka injection belimumab.

Hoʻokumu paha ʻo Belimumab i nā hopena ʻaoʻao. E haʻi i kāu kauka inā koʻikoʻi kekahi o kēia mau ʻōuli a mai hele aku paha:

• nausea
• pāhoehoe
• ʻeha poʻo a migraine paha
• paʻakikī e hiamoe a hiamoe paha
• ʻulaʻula, ʻili, ʻōhū, ʻeha, discoloration, a i ʻole nā ​​ukiuki ma ke kahua o ka injection
• ʻeha ma nā lima a me nā wāwae
• ihu ihope

Hiki i kekahi o nā hopena ʻaoʻao ke koʻikoʻi. Inā ʻoe e ʻike i kekahi o kēia mau ʻōuli a i ʻole nā ​​mea i helu ʻia i ka ʻaoʻao HOW, e kāhea koke i kāu kauka:

• hūwī
• hives
• ʻūlili
• pokole o ka hanu
• pehu o ka maka, puʻu, alelo, lehelehe, a me nā maka
• pilikia i ka hanu ʻana a i ʻole ke ale ʻana
• fiva, ʻāʻī puʻupuʻu, ʻalalā, ʻū, a me nā hōʻailona ʻē aʻe o ka maʻi
• mehana; ʻulaʻula, a ʻeha ʻeha a ʻeha paha ma kou kino
• ke noʻonoʻo nei i ka hōʻino a pepehi paha iā ʻoe iho a i ʻole nā ​​mea ʻē aʻe, a i ʻole ke hoʻolālā a hoʻāʻo ʻana paha e hana pēlā
• hou a i ʻole worsening kaumaha a hopohopo paha
• nā loli maʻamau i kāu hana a me kou ʻano
• ke hana nei i nā hoʻoikaika hoʻoweliweli
• pinepine, ʻeha, a i ʻole urination paʻakikī
• mimi ʻōpua a me ka ikaika paha
• e ʻū ana i ka huehue
• loli ka hihiʻo
• poho hoʻomanaʻo
• paʻakikī e noʻonoʻo pono
• paʻakikī e kamaʻilio a hele wāwae paha
• pākī a nalowale paha o ke kaulike

Hiki i Belimumab ke hoʻonui i kou makaʻi i kekahi mau maʻi ʻaʻai. Ua hōʻike ʻia nā noiʻi ua ʻoi aku ka make o ka poʻe i loaʻa ka belimumab mai nā kumu like ʻole ma mua o ka poʻe i lawe ʻole i belimumab. E kamaʻilio me kāu kauka e pili ana i ka makaʻu o ka loaʻa ʻana o kēia lāʻau.

Hoʻokumu paha ʻo Belimumab i nā hopena ʻē aʻe. Kāhea i kāu kauka inā loaʻa iā ʻoe kekahi pilikia maʻamau i ka hoʻohana ʻana i kēia lāʻau.

Inā ʻoe e ʻike i kahi hopena koʻikoʻi, e hoʻouna ʻoe a i ʻole kāu kauka i kahi hōʻike i ka papahana hōʻike ʻino a MedWatch Adverse Event Food (FDA) ma ka pūnaewele (http://www.fda.gov/Safety/MedWatch) a i ʻole kelepona. 1-800-332-1088).

E mālama i kēia lāʻau i loko o ka pūʻolo i komo ai, mai ka mālamalama, paʻa paʻa ʻia, a me kahi hiki ʻole i nā keiki. Mai hoʻoluliluli i nā autoinjectors a i ʻole nā ​​syringes prefilled i loaʻa ka belimumab. E mālama i ka injection belimumab i loko o ka pahu hau; mai paʻa hau. Hōʻalo i ka wela. Hiki ke mālama ʻia nā syringes ma waho o ka pahu hau (a hiki i 30 ° C) a hiki i nā hola he 12 inā pale ʻia mai ka lā o ka lā. Mai hoʻohana i nā syringes a mai hoʻihoʻi iā lākou i loko o ka pahu hau inā ʻaʻole i hoʻopili ʻia ma mua o 12 mau hola. E hoʻolei i nā lāʻau i hala i ka wā a pono ʻole paha. E kamaʻilio me kāu kauka lāʻau e pili ana i ka hoʻolei kūpono ʻana o kāu lāʻau.

He mea nui e mālama i nā lāʻau āpau mai ka maka a hiki i nā keiki e like me nā ipu (e like me nā minder pill i kēlā me kēia pule a me nā mea no nā kulu maka, nā kalima, nā pākuʻi, a me nā inhalers) ʻaʻole pale keiki a hiki i nā keiki ʻōpio ke wehe maʻalahi iā lākou. No ka pale ʻana i nā keiki ʻōpio mai ka lāʻau make, laka mau i nā pāpale palekana a kau koke i ka lāʻau i kahi palekana - kahi i luna a mamao a mai ko lākou alo a hiki. http://www.upandaway.org

Pono e hoʻolei ʻia nā lāʻau i koi ʻole ʻia i nā ala kūikawā e hōʻoia i ka hiki ʻole i nā holoholona, ​​nā keiki, a me nā poʻe ʻē aʻe ke hoʻopau iā lākou. Eia nō naʻe, ʻaʻole pono ʻoe e kaomi i kēia lāʻau i ka lua. Akā, ʻo ke ala ʻoi loa e hoʻolilo i kāu lāʻau i loko o kahi papahana hoʻihoʻi lāʻau. E kamaʻilio me kāu kauka lāʻau a kāhea paha i kāu ʻōpala a me nā hana hoʻopōʻaiapuni kūloko e aʻo e pili ana i nā papahana hoʻihoʻi i kou kaiāulu. E ʻike i ka pūnaewele palekana o kā FDA's Disposal of Medicines (http://goo.gl/c4Rm4p) no ka ʻike hou aku inā ʻaʻohe ou komo i kahi papahana hoʻihoʻi.

I ke kumu o ka overdose, e kāhea i ka helpline kaohi lāʻau make ma 1-800-222-1222. Loaʻa ka ʻike ma ka pūnaewele ma https://www.poisonhelp.org/help. Inā ua hina ka mea i hoʻomāinoino ʻia, loaʻa ka hopu ʻana, pilikia i ka hanu ʻana, a i ʻole hiki ʻole ke ala aʻe, e kāhea koke i nā lawelawe kūikawā ma 911.

Mālama i nā manawa āpau me kāu kauka.

E nīnau i kāu kauka lāʻau i nā nīnau āu e pili ana i ka injection belimumab.

He mea nui iā ʻoe e mālama i kahi papa inoa i kākau ʻia a me nā lāʻau lapaʻau ʻole (over-the-counter) lāʻau āu e lawe nei, a me nā huahana e like me nā huaora, nā minelala, a i ʻole nā ​​mea hoʻopiliʻai aʻe. Pono ʻoe e lawe i kēia papa inoa me ʻoe i kēlā me kēia manawa ke kipa ʻoe i ke kauka a i ʻole inā ʻae ʻia ʻoe i kahi haukapila. He ʻike nui nō hoʻi ia e lawe pū me ʻoe inā pilikia ʻo ka pilikia.

• ʻO Benlysta^®